The extreme dilution and lack of financials create high uncertainty. Existing shareholders face severe ownership dilution. Watch for trading volume and price discovery over the next 10 business days as the stock trades under the old name before the ticker symbol potentially updates. Any subsequent filing with pro forma financials or asset valuations will be critical to assess fair value.
Price Chart
Executive Summary
SRx Health Solutions closed its acquisition of EMJ Crypto Technologies, issuing 268.3M common shares, 117.3M exchangeable shares, and 44.4M warrants — massive dilution that transforms the company into an AI-driven digital-asset treasury platform under the new name SRX Global. No financial data or pro forma statements were provided, making the post-merger valuation and earnings power entirely speculative.
Key Facts
- Acquired 100% of EMJ Crypto Technologies and CCC Crypto Corp. in a share exchange transaction.
- Issued 268,346,659 common shares, 117,268,196 exchangeable shares (one-for-one into common), and warrants for 44,368,530 common shares — total potential dilution of ~430M shares.
- Company changed name to SRX Global Inc.; ticker remains SRXH.
- New management: Kent Cunningham (CEO), Eric Jackson (President, EMJX & Head of Asset Management), Nina Martinez (CFO).
- Company pivots to AI-driven capital allocation into high-conviction operating companies and digital assets; no revenue or earnings guidance provided.
Financial Impact
Massive dilution — up to 430 million new shares issued or issuable against a pre-deal market cap of $118M, implying a post-deal share count increase of many multiples. No financial data disclosed to assess the value of acquired assets or ongoing operations.
Risk Factors
- Extreme dilution from ~430M potential shares could overwhelm existing equity value.
- No financial statements or pro forma data provided — inability to value the acquired business.
- Speculative business model as a digital-asset treasury and AI investment platform with no track record of earnings.
- Forward-looking statements only; no concrete guidance or revenue figures.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-029254 |
| Exhibit: ex99-1.htm | 0001493152-26-029254 |
| Document: 0001493152-26-029254-index-headers.html | 0001493152-26-029254 |
| Document: 0001493152-26-029254-index.html | 0001493152-26-029254 |
| Document: 0001493152-26-029254.txt | 0001493152-26-029254 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | 8-K | $1.51 $1.60 | ▲ +5.96% | ▲ +6.62% | $1.61 (+6.62%) |
Sep 2, 2026 4w ago | 8-K | $1.56 $1.59 | ▲ +1.92% | ▲ +3.07% | $1.61 (+3.21%) |
Aug 28, 2026 5w ago | 8-K | $1.68 $1.59 | ▲ +5.65% | ▲ +5.51% | $1.61 (+4.17%) |
Aug 19, 2026 6w ago | 8-K | $1.87 $1.84 | ▼ −1.60% | ▼ −1.22% | $1.61 (−13.90%) |
Aug 4, 2026 8w ago | Press Release | $1.37 $1.84 | ▲ +34.31% | ▲ +34.41% | $1.61 (+17.52%) |
Aug 3, 2026 8w ago | Press Release | $1.44 $1.73 | ▲ +20.14% | ▲ +18.11% | $1.61 (+11.81%) |
Jul 30, 2026 9w ago | Press Release | $1.48 $1.43 | ▼ −3.38% | ▼ −7.00% | $1.61 (+8.78%) |
Jul 28, 2026 9w ago | 8-K | $1.48 $1.44 | ▲ +2.70% | ▲ +4.97% | $1.61 (−8.78%) |
Jul 16, 2026 11w ago | 8-K | $2.41 $1.80 | ▼ −25.31% | ▼ −23.64% | $1.61 (−33.20%) |
Jul 16, 2026 11w ago | Press Release | $2.41 $1.80 | ▼ −25.31% | ▼ −23.64% | $1.61 (−33.20%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access